Pioglitazone Reverses Insulin Resistance in Type 2 Diabetes

Pioglitazone Reverses Insulin Resistance in Type 2 DiabetesĀ – MM1311

Insulin resistance is a common featureĀ and contains several cardiovascularĀ risk factors: dyslipidaemia, hypertension,Ā glucose intolerance, hypercoagulability,
obesity, hyperinsulinaemia andĀ low-grade inflammation.

Modern Medicine – November/December 2013

Verified by ExactMetrics